{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:08:30Z","timestamp":1772820510600,"version":"3.50.1"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2018,6,5]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Our objective is to estimate the effects associated with higher rates of renin\u2010angiotensin system antagonists, angiotensin\u2010converting enzyme inhibitors and angiotensin receptor blockers (\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>\n              s), in secondary prevention for geriatric (aged &gt;65 years) patients with new ischemic strokes by chronic kidney disease (\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              ) status.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The effects of\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>\n              s on survival and renal risk were estimated by\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              status using an instrumental variable (\n              <jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content>\n              ) estimator. Instruments were based on local area variation in\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>\n              use. Data abstracted from charts were used to assess the assumptions underlying the instrumental estimator.\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>\n              s were used after stroke by 45.9% and 45.2% of\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              and non\u2010\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              patients, respectively.\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>\n              rate differences across local areas grouped by practice styles were nearly identical for\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              and non\u2010\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              patients. Higher\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>\n              use rates for non\u2010\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              patients were associated with higher 2\u2010year survival rates, whereas higher\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>\n              use rates for patients with\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              were associated with lower 2\u2010year survival rates. While the negative survival estimates for patients with\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              were not statistically different from zero, they were statistically lower than the estimates for non\u2010\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              patients. Confounders abstracted from charts were not associated with the instrumental variable used.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Higher\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>\n              use rates had different survival implications for older ischemic stroke patients with and without\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              .\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>\n              s appear underused in ischemic stroke patients without\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              as higher use rates were associated with higher 2\u2010year survival rates. This conclusion is not generalizable to the ischemic stroke patients with\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              , as higher\n              <jats:styled-content style=\"fixed-case\">ACEI<\/jats:styled-content>\n              \/\n              <jats:styled-content style=\"fixed-case\">ARBS<\/jats:styled-content>\n              use rates were associated with lower 2\u2010year survival rates that were statistically lower than the estimates for non\u2010\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              patients.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.118.009137","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T09:20:05Z","timestamp":1527672005000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Use of Angiotensin\u2010Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?"],"prefix":"10.1161","volume":"7","author":[{"given":"John M.","family":"Brooks","sequence":"first","affiliation":[{"name":"Arnold School of Public Health, University of South Carolina, Columbia, SC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole G.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Arnold School of Public Health, University of South Carolina, Columbia, SC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Suneja","sequence":"additional","affiliation":[{"name":"University of Iowa Hospitals and Clinics, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary C.","family":"Schroeder","sequence":"additional","affiliation":[{"name":"University of Iowa College of Pharmacy, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle A.","family":"Fravel","sequence":"additional","affiliation":[{"name":"University of Iowa College of Pharmacy, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Schneider Research Associates, Des Moines, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Wilwert","sequence":"additional","affiliation":[{"name":"Schneider Research Associates, Des Moines, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2010Jhen","family":"Li","sequence":"additional","affiliation":[{"name":"Arnold School of Public Health, University of South Carolina, Columbia, SC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Chrischilles","sequence":"additional","affiliation":[{"name":"University of Iowa College of Public Health, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas W.","family":"Brenton","sequence":"additional","affiliation":[{"name":"Schneider Research Associates, Des Moines, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Brenton","sequence":"additional","affiliation":[{"name":"Schneider Research Associates, Des Moines, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Robinson","sequence":"additional","affiliation":[{"name":"University of Iowa College of Public Health, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32833f3897"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000024"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02472.x"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.5301\/JN.2011.6445"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000228536"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000159"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078465"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.12.034"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009050546"},{"key":"e_1_3_5_11_2","first-page":"171","article-title":"\u2018To block or not to block\u2019; whether to continue renin\u2010angiotensin\u2010aldosterone system blockade in advanced chronic kidney disease","volume":"31","author":"Solbu MD","year":"2016","unstructured":"Solbu MD, Jardine AG. \u2018To block or not to block\u2019; whether to continue renin\u2010angiotensin\u2010aldosterone system blockade in advanced chronic kidney disease. Nephrol Dial Transplant. 2016;31:171\u2013173.","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00470111"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2003.00484.x"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604113341502"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042167"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007101136"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000447068"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.280"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284427"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.12700"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001999"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170874"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j791"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.050"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.12176"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12916"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0887-378X.2004.00327.x"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-018-0380-z"},{"key":"e_1_3_5_31_2","first-page":"810","article-title":"Which rate is right?","volume":"315","author":"Wennberg JE","year":"1986","unstructured":"Wennberg JE. Which rate is right? N Engl J Med. 1986;315:810\u2013815.","journal-title":"N Engl J Med"},{"key":"e_1_3_5_32_2","volume-title":"Health Economics","author":"Phelps CE","year":"1997","unstructured":"Phelps CE. Health Economics. Reading, Massachusetts: Addison\u2010Wesley; 1997."},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000322"},{"key":"e_1_3_5_34_2","first-page":"75","article-title":"The marginal benefits of invasive treatments for acute myocardial infarction: does insurance coverage matter?","volume":"37","author":"Brooks JM","year":"2000","unstructured":"Brooks JM, McClellan M, Wong HS. The marginal benefits of invasive treatments for acute myocardial infarction: does insurance coverage matter? Inquiry. 2000;37:75\u201390.","journal-title":"Inquiry"},{"key":"e_1_3_5_35_2","first-page":"1061","article-title":"Instrumental variables analysis applications in health services research\u2014a special supplement to HSR\u2014overview of supplement issue","volume":"35","author":"McClellan M","year":"2000","unstructured":"McClellan M, Newhouse JP. Instrumental variables analysis applications in health services research\u2014a special supplement to HSR\u2014overview of supplement issue. Health Serv Res. 2000;35:1061\u20131069.","journal-title":"Health Serv Res"},{"key":"e_1_3_5_36_2","first-page":"1337","article-title":"Who is the marginal patient? Understanding instrumental variables estimates of treatment effects","volume":"33","author":"Harris KM","year":"1998","unstructured":"Harris KM, Remler DK. Who is the marginal patient? Understanding instrumental variables estimates of treatment effects. Health Serv Res. 1998;33:1337\u20131360.","journal-title":"Health Serv Res"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-391"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)00078-0"},{"key":"e_1_3_5_39_2","unstructured":"Bang D Piccirillo JF Littenberg B Johnston A. The adult comorbidity evaluation\u201027 (ACE\u201027) test: a new comorbidity index for patients with cancer. 36th Annual Meeting of the American Society of Clinical Oncology. 2000."},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e318284056a"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.19.12.1497"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.3109\/09638288809164103"},{"key":"e_1_3_5_43_2","article-title":"Stroke scales: an update","author":"National Stroke Association","year":"2006","unstructured":"National Stroke Association . Stroke scales: an update. Stroke Clin Updates. 2006. Available at: https:\/\/www.yumpu.com\/en\/document\/view\/11589747\/stroke-scales-an-update-national-stroke-association. Accessed February 12, 2016.","journal-title":"Stroke Clin Updates"},{"key":"e_1_3_5_44_2","unstructured":"Deutsch A Kline T Lines LM Coots L Garfinkel D. Analysis of crosscutting Medicare functional status quality metrics using the continuity and assessment record and evaluation (CARE) item set: Final report. 2012."},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000026"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_3_5_47_2","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic","volume":"37","author":"Viera AJ","year":"2005","unstructured":"Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360\u2013363.","journal-title":"Fam Med"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.5600\/mmrr.003.04.a01"},{"key":"e_1_3_5_49_2","unstructured":"Chronic Condition Warehouse . 27 chronic condition algorithms. 2011. Available at: https:\/\/www.ccwdata.org\/web\/guest\/condition-categories. Accessed March 15 2016."},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2318"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2322"},{"key":"e_1_3_5_53_2","unstructured":"Carnahan R Gagne J Nelson J Fireman B Shoaibi A Reichman M Zhang R Levenson M Graham D Tiwari R Southworth M Archdeacon P Chakravarty A Goulding M Brown J Fuller C Toh D Chrischilles E. Mini\u2010sentinel prospective routine observational monitoring program tools (PROMPT): rivaroxaban surveillance version 2. 2014."},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.2.169"},{"key":"e_1_3_5_55_2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1475-6773.2006.00554.x","article-title":"Accuracy of hospital report cards based on administrative data","volume":"41","author":"Glance LG","year":"2006","unstructured":"Glance LG, Dick AW, Osler TM, Mukamel DB. Accuracy of hospital report cards based on administrative data. Health Serv Res. 2006;41:1413\u20131437.","journal-title":"Health Serv Res"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.560433"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.2.656"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(00)00256-0"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2312"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040135"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(03)00246-4"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200210000-00004"},{"key":"e_1_3_5_63_2","first-page":"1403","article-title":"Use of beta\u2010blocker therapy in older patients after acute myocardial infarction in Ontario","volume":"161","author":"Rochon PA","year":"1999","unstructured":"Rochon PA, Anderson GM, Tu JV, Clark JP, Gurwitz JH, Szalai JP, Lau P. Use of beta\u2010blocker therapy in older patients after acute myocardial infarction in Ontario. CMAJ. 1999;161:1403\u20131408.","journal-title":"CMAJ"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2004.10.004"},{"key":"e_1_3_5_65_2","first-page":"1513","article-title":"Eight Americas: investigating mortality disparities across races, counties, and race\u2010counties in the United States (vol 3, pg 4, 2005)","volume":"3","author":"Murray CJL","year":"2006","unstructured":"Murray CJL, Kulkarni SC, Michaud C, Tomijima N, Bulzacchelli MT, Iandiorio TJ, Ezzati M. Eight Americas: investigating mortality disparities across races, counties, and race\u2010counties in the United States (vol 3, pg 4, 2005). PLoS Med. 2006;3:1513\u20131524.","journal-title":"PLoS Med"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1257\/jep.15.4.69"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.3.278"},{"key":"e_1_3_5_68_2","first-page":"127854","article-title":"Survival implications associated with variation in mastectomy rates for early\u2010staged breast cancer","volume":"2012","author":"Brooks JM","year":"2012","unstructured":"Brooks JM, Chrischilles EA, Landrum MB, Wright KB, Fang G, Winer EP, Keating NL. Survival implications associated with variation in mastectomy rates for early\u2010staged breast cancer. Int J Surg Oncol. 2012;2012:127854.","journal-title":"Int J Surg Oncol"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181e41bb2"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.2307\/3001616"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.2307\/1910133"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1996.10476902"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.04.007"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1198\/07350010152472571"},{"key":"e_1_3_5_75_2","volume-title":"An Introduction to Modern Econometrics Using Stata","author":"Baum CF","year":"2006","unstructured":"Baum CF. An Introduction to Modern Econometrics Using Stata. College Station, TX: Stata Press; 2006."},{"key":"e_1_3_5_76_2","volume-title":"Econometric Analysis","author":"Greene WH","year":"2008","unstructured":"Greene WH. Econometric Analysis. Englewood Cliffs, NJ: Prentiss\u2010Hall; 2008."},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.23.100901.140546"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.1086\/230638"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/68.3.589"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.2307\/2171753"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12463"},{"key":"e_1_3_5_82_2","volume-title":"Introductory Econometrics: A Modern Approach","author":"Wooldridge JM","year":"2003","unstructured":"Wooldridge JM. Introductory Econometrics: A Modern Approach. Mason, OH: Thomson South\u2010Western; 2003."},{"key":"e_1_3_5_83_2","volume-title":"Handbook of Methods of Applied Statistics","author":"Chakravart IM","year":"1967","unstructured":"Chakravart IM, Laha RG, Roy J. Handbook of Methods of Applied Statistics. Hoboken: John Wiley and Sons; 1967."}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.118.009137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:57:55Z","timestamp":1715597875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.118.009137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":82,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,6,5]]}},"alternative-id":["10.1161\/JAHA.118.009137"],"URL":"https:\/\/doi.org\/10.1161\/jaha.118.009137","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"2018-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e009137"}}